Skip to content

BCPE Eagle GP, LLC

Follow

13F filer, CIK 1911134, Boston, MA

BCPE Eagle GP, LLC filed a 13F-NT notice for the quarter ended 2026-09-30 on 2026-11-16.

Accepted , ingested 13F-NT 0001193125-26-461989

This filer reports no holdings of its own for Q3 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.

Changes against Q2 2026 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.

Part of the filer group Bain Capital Life Sciences Investors, LLC

How groups are built

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • SGRY SURGERY PARTNERS INC: 13D/A 30,055,197 shares, 22.96% of the class, 13D/A filed 2026-10-26, 0001193125-26-431228Timeline
    Accepted , ingested
  • ADCT ADC THERAPEUTICS SA: 13G 14,825,625 shares, 9.99% of the class, 13G filed 2026-10-29, 0001193125-26-438199Timeline
    Accepted , ingested

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-NT 0001193125-26-461989 notice2026-11-16

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-NT 0001193125-26-461989 Quarter ended 2026-09-302026-11-16
13F-NT 0001193125-26-350467 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-NT 0001193125-26-225263 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-NT 0001193125-26-053030 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-NT 0001193125-25-281464 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-NT 0000950123-25-008019 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-NT 0000950123-25-005432 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-NT 0000950123-25-002736 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-NT 0000950123-24-011437 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-NT 0000950123-24-007821 Quarter ended 2024-06-302024-08-12acceptance time not in the bulk data set
13F-NT 0000950123-24-005296 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-NT 0000950123-24-001919 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-NT 0000950123-23-010829 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-NT 0000950123-23-008160 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-NT 0000950123-23-005365 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-NT 0000950123-23-002147 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-NT 0000950123-22-012267 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-NT 0000950123-22-009030 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-NT 0000950123-22-006430 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-NT 0000950123-22-002860 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set